Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2012, Vol. 13 Issue (11): 948-954    DOI: 10.1631/jzus.B1200179
Communications     
Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults
Jing-jing Ren, Xue-wei Dai, Zheng-gang Jiang, Ling-zhi Shen, Yong-di Chen, Qian Li, Wen Ren, Ying Liu, Jun Yao, Lan-juan Li
State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Key Laboratory of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China; Department of Epidemiology and Statistics, School of Medicine, Ningbo University, Ningbo 315000, China; Zhejiang Center for Disease Control and Prevention, Hangzhou 310003, China; Department of Family Medicine, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: To evaluate the immunological effects of three types of domestic 10-µg/dose hepatitis B vaccines in adults compared with a foreign vaccine, and to provide scientific evidence in support of adult hepatitis B vaccination. Methods: Adults from five counties (Deqing, Changxing, Nanxun, Wuxing, Anji) in Huzhou City, Shaoxing County and Tongxiang County, Zhejiang Province, China were selected. Blood samples were taken to assess serum HBsAg, anti-HBs, and anti-HBc using a chemiluminescence immunoassay. Adults, aged 16 to 49 years and who were anti-HBs negative at baseline, received hepatitis B immunizations at 0, 1, and 6 months. Anti-HBs levels were assessed one month after the third and final vaccination. Results: A total of 1872 adults were immunized and the average positive rate was 89.5%. Four types of hepatitis B vaccine were used, including three from Chinese companies (Shenzhen Kangtai, Dalian High-Tech, and North China Pharmaceutical) and one from a UK company (GlaxoSmithKline). Their seroconversion rates were 81.67%, 95.05%, 89.64%, and 86.81%, respectively. There was a significant difference between the anti-HBs positive conversion rates of the four types (P<0.005) but the seroconversion rates among the different vaccines were not significantly different (χ2=2.123, P=0.145). The average anti-HBs geometric mean titers (GMTs) of non-immune adults immunized with each of the four vaccines were 177.28, 473.23, 246.13, and 332.20 mIU/ml, respectively. There were no statistically significant differences in the GMTs between the three types of domestic vaccine and the foreign vaccine (t=−1.575, P=0.116). Conclusions: Domestic recombinant hepatitis B vaccines can achieve immunization effects comparable to those of a foreign vaccine.

Key wordsHepatitis B      Vaccines      Immunization      Geometric mean titer     
Received: 27 June 2012      Published: 05 November 2012
CLC:  R575.1  
Cite this article:

Jing-jing Ren, Xue-wei Dai, Zheng-gang Jiang, Ling-zhi Shen, Yong-di Chen, Qian Li, Wen Ren, Ying Liu, Jun Yao, Lan-juan Li. Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(11): 948-954.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1200179     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2012/V13/I11/948

[1] Jing-yao Pang, Kui-jun Zhao, Jia-bo Wang, Zhi-jie Ma, Xiao-he Xiao. Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(6): 533-539.
[2] Xinguo Jiang. Harnessing the immune system for the treatment of breast cancer[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2014, 15(1): 1-15.
[3] Yong MAO, Xin HUANG, Ke YU, Hai-bin QU, Chang-xiao LIU, Yi-yu CHENG. Metabonomic analysis of hepatitis B virus-induced liver failure: identification of potential diagnostic biomarkers by fuzzy support vector machine[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(6): 474-481.
[4] Xing-guo ZHANG, Jing MIAO, Min-wei LI, Sai-ping JIANG, Fu-qiang HU, Yong-zhong DU. Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2008, 9(6): 506-510.
[5] LIU Ke-zhou, HOU Wei, ZUMBIKA Edward, NI Qin. Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2005, 6(12): 8-.
[6] LI Min-wei, HOU Wei, WO Jian-er, LIU Ke-zhou. Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2005, 6( 7): 10-.
[7] CHEN Zhe, XU Ze-feng, YE Jing-jia, YAO Hang-ping, ZHENG Shu, DING Jia-yi. Combination of small interfering RNAs mediates greater inhibition of human hepatitis B virus replication and antigen expression[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2005, 6( 4): 3-.
[8] CHEN Xiao-hong, CHEN Zhi, YAO Hang-ping, CHEN Feng, ZHU Hai-hong, ZHOU Hong-juan. Construction and characterization of a cDNA library from human liver tissue with chronic hepatitis B[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2005, 6( 4): 11-.